| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76774-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74486 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64952SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide Free | NB100-64387SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-63574-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-43426-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65537-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76689-0.025mg | |||
![Western Blot: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen (A) tissue lysate, K562 (B), and U937 (C) cell lysates with BCMA antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Western-Blot-NBP1-76774-img0002.jpg "Western Blot: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen (A) tissue lysate, K562 (B), and U937 (C) cell lysates with BCMA antibody at 5 ug/ml.")
![Immunohistochemistry-Paraffin: BCMA/TNFRSF17 Antibody [NBP1-76774] - Human spleen tissue with BCMA antibody at 10 ug/mL.](http://images.novusbio.com/fullsize/BCMA-TNFRSF17-Antibody-Immunohistochemistry-Paraffin-NBP1-76774-img0005.jpg)
![Immunocytochemistry/ Immunofluorescence: BCMA/TNFRSF17 Antibody - BSA Free [NBP1-76774] - Immunofluorescence of BCMA/TNFRSF17 in Human Spleen tissue with BCMA/TNFRSF17 antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp1-76774_rabbit-polyclonal-bcma-tnfrsf17-antibody-2711202420285861.jpg)
![Immunohistochemistry: BCMA/TNFRSF17 Antibody - BSA Free [NBP1-76774] - Immunohistochemistry of BCMA/TNFRSF17 in human spleen tissue with BCMA/TNFRSF17 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76774_rabbit-polyclonal-bcma-tnfrsf17-antibody-2711202420414573.gif)
![Western Blot: TDO2 Antibody (OTI2A4) [NBP2-45995] -Analysis of overexpressedlysates(15ug per lane) from HEK293T cellstransfected with empty plasmid , lane1) , human TDO2 plasmid , lane 2),mouse TDO2 plasmid, lane 3) usinganti-TDO2 antibody (1:500). Figure B,Western blot analysis of the same samples asfigure A with anti-DDK antibody, 1:1000)](http://images.novusbio.com/fullsize/antibody/nbp2-45995_mouse-tdo2-mab-oti2a4-western-blot-342025113045..png "Western Blot: TDO2 Antibody (OTI2A4) [NBP2-45995] -Analysis of overexpressedlysates(15ug per lane) from HEK293T cellstransfected with empty plasmid , lane1) , human TDO2 plasmid , lane 2),mouse TDO2 plasmid, lane 3) usinganti-TDO2 antibody (1:500). Figure B,Western blot analysis of the same samples asfigure A with anti-DDK antibody, 1:1000)")
![Flow Cytometry: CD21 Antibody (Bu33) [NB100-63574] - Flow Cytometry: CD21 Antibody (Bu33) [Alexa Fluor 647] [NB100-63574AF647] - A surface stain was performed on human peripheral blood lymphocytes with CD21 (Bu33) antibody NB100-63574AF647 and a matched isotype control NBP2-27287AF647. Cells were incubated in an antibody dilution of 2 ug/mL for 20 minutes at room temperature. A co-stain was performed with NBP2-26646. Image using the Alexa Fluor 647 form of this antibody.](http://images.novusbio.com/fullsize/CD21-Antibody-Bu33-Flow-Cytometry-NB100-63574-img0004.jpg "Flow Cytometry: CD21 Antibody (Bu33) [NB100-63574] - Flow Cytometry: CD21 Antibody (Bu33) [Alexa Fluor 647] [NB100-63574AF647] - A surface stain was performed on human peripheral blood lymphocytes with CD21 (Bu33) antibody NB100-63574AF647 and a matched isotype control NBP2-27287AF647. Cells were incubated in an antibody dilution of 2 ug/mL for 20 minutes at room temperature. A co-stain was performed with NBP2-26646. Image using the Alexa Fluor 647 form of this antibody.")
![Flow Cytometry: CD21 Antibody (Bu33) [NB100-63574] - Using the Alexa Fluor 488 direct conjugate A surface stain was performed on human peripheral blood lymphocytes with CD21 (Bu33) antibody NB100-63574AF488 and a matched isotype control. Cells were incubated in an antibody dilution of 5 ug/mL for 20 minutes at room temperature. A co-stain was performed with NBP2-25196AF647.](http://images.novusbio.com/fullsize/CD21-Antibody-Bu33-Flow-Cytometry-NB100-63574-img0001.jpg)
![Flow Cytometry: CD21 Antibody (Bu33) [NB100-63574] - Using the Allophycocyanin direct conjugate A cell surface stain was performed on Daudi cells with CD21 Antibody (Bu33) NB100-63574APC (blue) and a matched isotype control NBP2-27287APC (orange). Cells were incubated in an antibody dilution of 0.5 ug/mL for 20 minutes at room temperature. Both antibodies were conjugated to allophycocyanin.](http://images.novusbio.com/fullsize/CD21-Antibody-Bu33-Flow-Cytometry-NB100-63574-img0002.jpg)
![Flow Cytometry: CD21 Antibody (Bu33) [NB100-63574] - Flow Cytometry: CD21 Antibody (Bu33) [Alexa Fluor 647] [NB100-63574AF647] - Immunophenotyping with Canine whole blood. image courtesy of customer. Image using the Alexa Fluor 647 form of this antibody.](http://images.novusbio.com/fullsize/CD21-Antibody-Bu33-Flow-Cytometry-NB100-63574-img0003.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE/Cy7 conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control PE-Cy7 (open histogram) or Anti-Human CD27 PE-Cy7 (filled histogram). Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0011.jpg "Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE/Cy7 conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control PE-Cy7 (open histogram) or Anti-Human CD27 PE-Cy7 (filled histogram). Cells in the lymphocyte gate were used for analysis.")
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the Allophycocyanin conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control APC (open histogram) or Anti-Human CD27 APC (filled histogram). Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0006.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the Biotin conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Anti-Human CD27 PE (left), and APC (right). Appropriate isotype controls were used (open histogram). Cells in the lymphocyte population were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0007.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the FITC conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Anti-Human CD19 APC and Mouse IgG1 K Isotype Control FITC (left) or Anti-Human CD27 FITC (right). Cells in the lymphocyte gate were used for analysis.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0008.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE conjugate of NBP1-43426. Analysis of human peripheral blood leukocytes using CD27 PE conjugate. This can be used at less than or equal to 1 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8 cells/test.](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0009.jpg)
![Flow Cytometry: CD27/TNFRSF7 Antibody (O323) [NBP1-43426] - Analysis using the PE/Cy5 conjugate of NBP1-43426. Staining of normal human peripheral blood cells with Mouse IgG1 K Isotype Control PE-Cy5 (open histogram) or 0.25 ug of Anti-Human CD27 PE-Cy5 (filled histogram).=](http://images.novusbio.com/fullsize/CD27-TNFRSF7-Antibody-O323-Flow-Cytometry-NBP1-43426-img0010.jpg)
![Flow Cytometry: B7-1/CD80 Antibody (2D10.4) [NBP1-43384] - Analysis using the PE/Cy5 conjugate of NBP1-43384. Staining of normal human peripheral blood cells with PE-Cy5 Mouse IgG1 kappa Isotype Control (open histogram) orAnti-Human CD80 (B7-1) PE-Cy5 (filled histogram).](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-2D10-4-Flow-Cytometry-NBP1-43384-img0006.jpg "Flow Cytometry: B7-1/CD80 Antibody (2D10.4) [NBP1-43384] - Analysis using the PE/Cy5 conjugate of NBP1-43384. Staining of normal human peripheral blood cells with PE-Cy5 Mouse IgG1 kappa Isotype Control (open histogram) orAnti-Human CD80 (B7-1) PE-Cy5 (filled histogram).")
![Flow Cytometry: B7-1/CD80 Antibody (2D10.4) [NBP1-43384] - Analysis using the FITC conjugate of NBP1-43384. Staining of the Daudi cell line with Mouse IgG1 kappa Isotype Control FITC (cat. 11-4714) (blue histogram) or Anti-Human CD80 (B7-1) FITC (purple histogram). Total viable cells were used for analysis.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-2D10-4-Flow-Cytometry-NBP1-43384-img0004.jpg)
![Flow Cytometry: B7-1/CD80 Antibody (2D10.4) [NBP1-43384] - Analysis using the PE conjugate of NBP1-43384. Analysis of human peripheral blood leukocytes using CD80 PE conjugage. This can be used at less than or equal to 1 ug per test. Cell number should be determined empirically but can range from 10^5to 10^8 cells/test.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-2D10-4-Flow-Cytometry-NBP1-43384-img0005.jpg)
![Immunohistochemistry-Paraffin: CD59 Antibody (YTH53.1) [NB100-65537] Immunoperoxidase staining of formalin fixed, paraffin embedded human placenta with Rat anti Human CD59](http://images.novusbio.com/fullsize/CD59-Antibody-YTH53-1-Immunohistochemistry-Paraffin-NB100-65537-img0002.jpg "Immunohistochemistry-Paraffin: CD59 Antibody (YTH53.1) [NB100-65537] Immunoperoxidase staining of formalin fixed, paraffin embedded human placenta with Rat anti Human CD59")
![Flow Cytometry: CD59 Antibody (YTH53.1) [NB100-65537] - Staining of human peripheral blood granulocytes with RAT ANTI HUMAN CD59 (NB100-65537).](http://images.novusbio.com/fullsize/CD59-Antibody-YTH53-1-Flow-Cytometry-NB100-65537-img0001.jpg)
![Western Blot: HVEM/TNFRSF14 Antibody [NBP1-76689] - Raji cell lysate with TNFRSF14 antibody at 2 u/mL in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/HVEM-TNFRSF14-Antibody-Western-Blot-NBP1-76689-img0001.jpg "Western Blot: HVEM/TNFRSF14 Antibody [NBP1-76689] - Raji cell lysate with TNFRSF14 antibody at 2 u/mL in (A) the absence and (B) the presence of blocking peptide.")
![Immunocytochemistry/ Immunofluorescence: HVEM/TNFRSF14 Antibody - BSA Free [NBP1-76689] - Immunofluorescence of HVEM/TNFRSF14 in Raji cells with HVEM/TNFRSF14 antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp1-76689_rabbit-polyclonal-hvem-tnfrsf14-antibody-2711202420352412.jpg)
![Immunocytochemistry/ Immunofluorescence: HVEM/TNFRSF14 Antibody - BSA Free [NBP1-76689] - Immunocytochemistry of HVEM/TNFRSF14 in Raji with HVEM/TNFRSF14 antibody at 10 u/mL.](http://images.novusbio.com/fullsize/nbp1-76689_rabbit-polyclonal-hvem-tnfrsf14-antibody-2711202420352442.jpg)
![Western Blot: HVEM/TNFRSF14 Antibody - BSA Free [NBP1-76689] - Western blot analysis of 5 ng of HVEM/TNFRSF14 with HVEM/TNFRSF14 antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/nbp1-76689_rabbit-polyclonal-hvem-tnfrsf14-antibody-2711202420171720.gif)
![Western Blot: NFATC2/NFAT1 Antibody [NBP1-51970] - NBP1-51970 (0.3ug/ml) staining of MOLT4 lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.](http://images.novusbio.com/fullsize/NFATC2-NFAT1-Antibody-Western-Blot-NBP1-51970-img0004.jpg "Western Blot: NFATC2/NFAT1 Antibody [NBP1-51970] - NBP1-51970 (0.3ug/ml) staining of MOLT4 lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.")
![Immunohistochemistry-Paraffin: NFATC2/NFAT1 Antibody [NBP1-51970] - NBP1-51970 (3.8ug/ml) staining of paraffin embedded Human Spleen. Steamed antigen retrieval with citrate buffer pH 6, AP-staining.](http://images.novusbio.com/fullsize/NFATC2-NFAT1-Antibody-Immunohistochemistry-Paraffin-NBP1-51970-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: CLEC16A Antibody [NBP1-00171] - Analysis of paraformaldehyde fixed A549 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing strong nuclear and weak cytoplasmic staining. Actin filaments were stained with phalloidin (red) and the nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).](http://images.novusbio.com/fullsize/CLEC16A-Antibody-Immunocytochemistry-Immunofluorescence-NBP1-00171-img0001.jpg "Immunocytochemistry/Immunofluorescence: CLEC16A Antibody [NBP1-00171] - Analysis of paraformaldehyde fixed A549 cells, permeabilized with 0.15% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL), showing strong nuclear and weak cytoplasmic staining. Actin filaments were stained with phalloidin (red) and the nuclear stain is DAPI (blue). Negative control: Unimmunized goat IgG (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (2 ug/mL).")
![Flow Cytometry: CLEC16A Antibody [NBP1-00171] - Analysis of paraformaldehyde fixed A549 cells (blue line), permeabilized with 0.5% Triton. Primary incubation 1hr (10 ug/mL) followed by Alexa Fluor 488 secondary antibody (1 ug/mL). IgG control: Unimmunized goat IgG (black line) followed by Alexa Fluor 488 secondary antibody.](http://images.novusbio.com/fullsize/CLEC16A-Antibody-Flow-Cytometry-NBP1-00171-img0002.jpg)
![Western Blot: NKG2D/CD314 Antibody [NB100-1891] - Staining of MOLT-4 cell lysate (A) + peptide (B) with antibody at 0.5 ug/mL (35ug protein in RIPA buffer). Detected by chemiluminescence.](http://images.novusbio.com/fullsize/NKG2D-CD314-Antibody-Western-Blot-NB100-1891-img0001.jpg "Western Blot: NKG2D/CD314 Antibody [NB100-1891] - Staining of MOLT-4 cell lysate (A) + peptide (B) with antibody at 0.5 ug/mL (35ug protein in RIPA buffer). Detected by chemiluminescence.")
![Flow Cytometry: NKG2D/CD314 Antibody [NB100-1891] - Flow cytometric analysis of human peripheral blood monocytes. Primary incubation 30 minutes (10ug/ml) followed by Alexa Fluor 488 secondary antibody (1ug/ml).](http://images.novusbio.com/fullsize/NKG2D-CD314-Antibody-Flow-Cytometry-NB100-1891-img0002.jpg)